Sentences with phrase «drug companies then»

Once discovered, drug companies then hire teams of lawyers to defeat injury claims.

«Until recently we have been looking for individual genes associated with diseases, which drug companies then target with treatments.

Not exact matches

Valeant has been at the center of a political firestorm over prescription medication costs and pharmaceutical companies, which depend more on acquiring or licensing existing therapies (and then raising their prices) rather than fueling R&D into new drugs.

And within a span of six weeks this fall, Hillary Clinton caused a drop in biotech stocks with a tweet calling for greater regulation of drug prices, then single - handedly tanked stocks of private - corrections companies when she tweeted about prison reform.

Valeant, as the story unfolded, bought existing medications from other drug makers, as well as whole companies - then relentlessly hiked the prices of the drugs it acquired.

It doesn't make the drugs itself; it leases medicines from companies, conducts phase 1 and 2 testing, and then it leases the drug to a larger business to conduct phase 3 testing.

Since then, the companies have been scrambling to rack up indications for the rival drugs, which are both approved for treating melanoma and lung cancer.

After generic drug maker Actavis bought Allergan last year, it took the name of the specialty pharmaceutical company; the reinvented Allergan then turned around and sold its legacy generic business to Teva Pharmaceutical Industries (TEVA) in July.

It then sells the coal at a loss to power plants to generate the real benefit for the drug company: credits that allow Mylan to lower its own tax bill.

The pharma company will then sell the drug to the public.

Early in the decade the company had been dogged by R&D failures, most notably of Vanlev, a high - profile hypertension drug that had been hailed as a can't - miss blockbuster but then fell short of even getting FDA approval.

Drug makers have asserted that benefits managers, who negotiate rebates and discounts with drug makers and then partially pass those savings on to insurance companies and consumers, are part of the reason that list prices have risen so much, since biopharma companies must incorporate the expected future discounts into their pricing strategDrug makers have asserted that benefits managers, who negotiate rebates and discounts with drug makers and then partially pass those savings on to insurance companies and consumers, are part of the reason that list prices have risen so much, since biopharma companies must incorporate the expected future discounts into their pricing strategdrug makers and then partially pass those savings on to insurance companies and consumers, are part of the reason that list prices have risen so much, since biopharma companies must incorporate the expected future discounts into their pricing strategies.

After years of buying up companies then raising the prices of their drugs — a strategy that rapidly amplified Valeant's revenue and stock price — Valeant is now struggling to grow by other means, while dealing with the consequences of its previous actions.

Sierra Oncology, Inc., a clinical stage drug development company focused on advancing next - generation DNA damage response therapeutics for the treatment of patients with cancer, went public near $ 29 in July 2015, then began a downtrend that continued through a June 2017 all - time low of $ 1.10.

If the drug companies» prices for a large chunk of Californians was pegged to the Veterans Affairs prices, that argument goes, then the companies would have less incentive to give the VA a sharply discounted price.

But what Sequoia married itself to was an offshore drug company that borrowed heavily to buy other drug companies, cut costs and research, then raised prices on many older drugs to astronomical heights.

Companies must currently produce the drug in their own facilities, then ship it using their own vehicles to their own dispensaries.

She then took a position as an associate consultant at Kantar Health assisting biopharmaceutical companies in forecasting the market potential of new drugs.

Normally a company invests a great deal of money in research and development to get a drug to market, then recoups that, and profits, by selling it.

Her first post-postdoc job, in 1988, was at Seattle - based Immunex, then a 7 - year - old company focused on developing drugs to treat immune - system disorders.

You know, that's the way cancer research works in this country too, where the federal government sponsors the initial research and then the pharmaceutical companies take advantage of what's been learned through drug screenings and they go and develop the drugs for profit.

An American who buys golf clubs abroad and doesn't want to declare them can send them via a company that packs them in a shipping container, which then slips them into port without ever being seen by customs agents; the ability of drug dealers to bypass even the most elaborate border controls is a well - known problem.

Supari's position all along has been that the evil drug companies will turn these viruses into vaccines, and then charge so much for their products that the poor countries the viruses came from will never be able to afford the life - saving products.

If they are on the market without generic versions to challenge them then companies can maintain monopoly prices, and in doing so harm consumers by preventing or delaying access to cheaper drugs.»

He then argues that homeopathy satisfies a real demand in healthcare, to the inconvenience of big drug companies, ignoring the fact that selling water and sugar to people is of great convenience to the big homeopathy companies.

Since then, in response to pressures from legislators, patient advocates, and pharmaceutical companies, the agency has continued to develop a variety of fast - track pathways that expedite the approval of new drugs and medical devices.

His work focused on drug company payments to a psychiatrist at the University of Cincinnati, another at Stanford University, and Charles Nemeroff, then with Emory University — causing much chaos and agitation among researchers — and changes in numerous academic conflict - of - interest policies.

Those were developed, in part, as a byproduct of previous alliances in which pharmaceutical companies payed for rights to develop would - be drugs discovered at Scripps, as well as through the more traditional approach of licensing early - stage compounds to startup companies that then raise money to develop them further.

From 1991 to 1994 Ciba - Geigy, the company that then manufactured Ritalin (it subsequently merged with Sandoz to become Novartis), gave $ 748,000 to the patient organization, prompting the U.S. Drug Enforcement Administration to note that «the relationship between Ciba - Geigy and CHADD raises serious concerns about CHADD's motive in proselytizing the use of Ritalin.»

We start with a compelling scientific idea or promising drug candidate from collaborators in academia and / or industry, and then efficiently advance the therapy through pre-clinical research to enable the establishment of an independent company to progress drug candidates through clinical and regulatory development to commercialization.

«Once we understand the mechanisms in the brain, then pharmaceutical companies will be able to develop more effective drugs, perhaps with fewer side effects than our current options,» she says.

He became Chief Scientific Officer in 2008, responsible for developing the company's research and drug discovery strategy, and then became Executive Vice President for Genentech Research and Early Development when Genentech merged with Roche in 2009.

Along with our collaborator in this program, Ludwig Cancer Research, we work to identify promising new drug combinations, partner with companies to gain access to these drugs, and then provide investment capital and clinical trial support to the academic investigators to help kick - start clinical development.

Then, in the early 80s, drug companies made another case for it and osteoporosis was the main indication.

Then, despite a promise from his agent that his new carrier would cover Enbrel, he was later informed that the company did nt cover injectable drugs.

The drug company pays for testing and then submits the results on paper to the FDA for approval.

Then, in the mid-80s, a drug company based in Indianapolis came up with a way to create synthetic HGH that was 100 % identical to the 191 - amino - acid growth hormone naturally produced by the body.

One thing leads to another, as tends to happen when you fall down rabbit holes of espionage and clandestine operations, and soon Barry is acting as a bagman in transactions between the Company and Panamanian strongman — and CIA informant — Manuel Noriega, and then he's smuggling drugs into the U.S. for the Medellin cartel, which leads to (after he's caught) becoming a DEA informant.

This shocking expose» was directed by Elizabeth Canner who devoted nine years to chronicling the drug companies» effort to get the Food and Drug Administration (FDA) first to recognize FSD as a medical disorder, and then to approve a class of prescription drugs as female versions of Viadrug companies» effort to get the Food and Drug Administration (FDA) first to recognize FSD as a medical disorder, and then to approve a class of prescription drugs as female versions of ViaDrug Administration (FDA) first to recognize FSD as a medical disorder, and then to approve a class of prescription drugs as female versions of Viagra.

The chief of research at Pfizer, then as now one of the more politically active pharmaceutical companies, had been railing against the efficacy rules for years, saying they got in the way of delivering good new drugs.

If a pharmaceutical company loses any of its drug manufacturing right / permission because of a regulatory effect, then it will definitely affect the company's profit and hence, the stock price.

If you're going to gamble on a company's new drug or cure for cancer then covered calls are probably not the right strategy.

«If I thought that company X was developing a new drug that would pass all FDA approvals and that wasn't priced into that stock, then you have to buy that,» he says.

Myrexis: Shares in Myrexis have performed miserably this year; first they sunk in January on news of the suspension of clinical trials on one of the four drugs in the company's pipeline and then again in May on the news of a management change.

Sequoia staked its fate to the performance of Valeant Pharmaceuticals, a firm adored by hedge fund managers and Sequoia — which plowed over a third of its portfolio into the stock — for its singular strategy: buy small drug companies with successful niche medicines, then skyrocket the price of those drugs.

Again, remember that their sponsors are the companies that sell the drugs, and then make a common sense decision based on your dog's real likelihood of getting bitten by mosquitoes in the middle of winter — as well as the risk of harm to your dog from the drugs.

Its no different then your family doctor getting free samples from drug companies.

And even then, the report them to the drug companies, not to the FDA.

I meant to also say the the pharmaceutical companies are part of the «they» joint venture — their business IS disease, and it is a win / win for them — they sell the stuff they are spraying and then sell their drugs to «help» the health problems they have created.

«Biopiracy suggests to me that someone in a dominant position — whether it be resources or sophistication like a drug company — would go and obtain from a weaker party — such as an indigenous population — materials or information that are then utilized to make a proprietary and profitable drug product.